AMA Journal of Ethics®

Illuminating the art of medicine

Journal of Ethics Header

AMA Journal of Ethics®

Illuminating the art of medicine

Virtual Mentor. December 2004, Volume 6, Number 12.

Suggested Reading and Resources

  • Print

Resources on Standards of Care: An Ethical Examination

Further Reading

  • Agency for Healthcare Research and Quality. AHRQ Profile. Available at: http://www.ahrq.gov/about/profile.htm. Accessed October 19, 2004.
  • Agency for Healthcare Research and Quality. Diagnosis and Treatment of Coronary Heart Disease in Women: Systematic Reviews of Evidence on Selected Topics. Evidence Report/Technology Assessment No. 81. (Prepared by the University of California, San Francisco-Stanford Evidence-based PracticeCenter under Contract No 290-97-0013.) AHRQ Publication No. 03-E037. Rockville, MD: Agency for Healthcare Research and Quality. May 2003. Available at: http://www.ahrq.gov/downloads/pub/evidence/pdf/ chdwomtop/contents.pdf. Accessed November 22, 2004.
  • Agency for Healthcare Research and Quality. National Guideline Clearinghouse (NGC) Disclaimer page. Available at: http://www.guideline.gov/about/disclaimer.aspx. Accessed October 13, 2004.
  • ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT). JAMA. 2002;288:2998-3007.
  • Alving B. Cholesterol guidelines: the strength of the science base and the integrity of the development process. NIH/NHLBI News Release. Available at: http://www.nhlbi.nih.gov/new/press/04-09-24.htm. Accessed October 6, 2004.
  • American Academy of Pediatrics and the American College of Obstetricians and Gynecologists. Human immunodeficiency virus screening. Joint statement of the American Academy of Pediatrics and the American College of Obstetricians and Gynecologists. Pediatrics. 1999;104:128.
  • American Medical Association Office of Quality Assurance. Attributes to Guide the Development of Practice Parameters. Chicago, IL: American Medical Association; 1990.
  • Opinion 9.07 Medical testimony. American Medical Association. Code of Medical Ethics 2008-2009 Edition. Chicago, IL: American Medical Association; 2008:314-317.
  • Annas GJ. Scientific evidence in the courtroom—the death of the Frye rule. N Engl J Med. 1994;330:1018-1021.
  • Atkins D, Best D, Briss PA, et al, and the GRADE Working Group. Grading quality of evidence and strength of recommendations. BMJ. 2004;328:1490-1494.
  • Atkins D, Best D, Shapiro EN, eds. Third US Preventive Services Task Force: background, methods and first recommendations. Am J Prev Med. 2001;20:1-108.
  • Aynalem G, Mendoza P, Fredrick T, et al. Who and why? HIV-testing refusal during pregnancy: implication for pediatric HIV epidemic disparity. AIDS Behav. 2004;8:25-31.
  • Baraff LJ. Management of fever without source in infants and children. Ann Emerg Med. 2000;36:602-614.
  • Barbacci M, Repke JT, Chaisson RE. Routine prenatal screening for HIV infection. Lancet. 1991; 337:709-711.
  • Bates DW, Gawande AA. Improving safety with information technology. N Engl J Med. 2003;348:2526-2534.
  • Bowman JG. Hospital standardization series: general hospitals of 100 or more beds, report for 1919. Bull Am Coll Surg. 1920;4:3-36.
  • Cannon CP, Braunwald E, McCabe CH, et al, for the Pravastatin or Atorvastatin Evaluation and Infection Therapy—Thrombolysis in Myocardial Infarction 22 Investigators. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med. 2004;350:1495-1504.
  • Canto JG, Allison JJ, Kiefe CI, et al. Relation of race and sex to the use of reperfusion therapy in Medicare beneficiaries with acute myocardial infarction. N Engl J Med. 2000;342:1094–1100.
  • Carusi D, Learman LA, Posner SF. Human immunodeficiency test refusal in pregnancy: a challenge to voluntary testing. Obstet Gynecol. 1998;91:540-545.
  • Centers for Disease Control. HIV/AIDS Surveillance Report, 2002. Atlanta: US Department of Health and Human Services, CDC. 14:13. Available at: http://www.cdc.gov/hiv/stats/hasrlink.htm. Accessed October 20, 2004.
  • Chassin MR, Brook RH, Park RE, et al. Variations in the use of medical and surgical services by the Medicare population. New Engl J Med. 1986;314:285-290.
  • Cochrane AL. 1931-1971: A critical review, with particular reference to the medical profession. In: Medicines for the Year 2000. London: Office of Health Economics; 1979:1-11.
  • Council of Medical Specialty Societies (CMSS). Standards of Quality in Patient Care: The Importance and Risks of Standard Setting. Published proceedings from an Invitational Conference of the CMSS; Washington, DC; September 25-26, 1987.
  • Cozen W, Mascola L, Enguidanos R, et al. Screening for HIV and hepatitis B in Los Angeles County prenatal clinics: a demonstration project. J Acquir Immune Defic Syndr. 1993;6:95-98.
  • Daubert v Merrell Dow Pharmaceuticals, Inc., 951 F.2d 1128 (9th Cir. 1991).
  • Daubert, et al v Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 589; 113 S. Ct. 2786 (1993).
  • DeAngelis C, Joffe A, Wilson M, et al. Iatrogenic risks and financial costs of hospitalizing febrile infants. Am J Dis Child. 1983;137:1146-1149.
  • Eccles M, McColl E, Steen N, et al. Effect of computerised evidence based guidelines on management of asthma and angina in adults in primary care: cluster randomized controlled trial. BMJ. 2002;325:941-944.
  • Epstein RM, Alper BS, Quill TE. Communicating evidence for participatory decision making. JAMA. 2004; 291:2359-2366.
  • Field MJ, Lohr KN, eds. Institute of Medicine. Clinical Practice Guidelines: Directions for a New Program. Washington, DC: National Academy Press; 1990. Available at: http://books.nap.edu/books/0309043468/html/index.html. Accessed October 25, 2004.
  • Fisher R, Ury W, Patton B. Getting to Yes: Negotiating Agreement Without Giving In. Boston: Houghton-Mifflin; 1981.
  • Flexner A. Medical Education in the United States and Canada. New York, NY: Carnegie Foundation; 1910.
  • Frye v US, 293 F.1013,1014 (1923).
  • Giuliano AR, Mokuau N, Hughes C, et al. Participation of minorities in cancer research: the influence of structural, cultural and linguistic factors. Ann Epidemiol. 2000;10(8 suppl):S22–S34.
  • Goodman KW. Ethics and Evidence-Based Medicine: Fallibility and Responsibility in Clinical Science. Cambridge: Cambridge University Press; 2003.
  • Goulding MR. Inappropriate medication prescribing for elderly ambulatory care patients. Arch Intern Med. 2004;164:305-312.
  • GRADE Working Group. Available at: http://www.gradeworkinggroup.org. Accessed September 1, 2004.
  • Grady D, Chaput L, Kristof M. Diagnosis and Treatment of Coronary Heart Disease in Women: Systematic Reviews of Evidence on Selected Topics. Evidence Report/Technology Assessment No. 81. (Prepared by the University of California, San Francisco-Stanford Evidence-based Practice Center under Contract No 290-97-0013.) AHRQ Publication No. 03-E037. Rockville, MD: Agency for Healthcare Research and Quality. May 2003. Available at: http://www.ahrq.gov/downloads/pub/evidence/pdf/chdwomtop/contents.pdf. Accessed November 22, 2004.
  • Grundy SM, Cleeman JI, Merz CN, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. Circulation. 2004;110:227-239.
  • Grundy SM, Cleeman JI, Merz CNB, et al. Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines. JACC. 2004;44:720-732.
  • Guyatt GH, Sackett DL, Sinclair JC, et al, for the Evidence Based Medicine Working Group. User's guide to the medical literature IX: a method for grading health care recommendations. JAMA. 1995;274:1800-1804.
  • Harbour R, Miller J. A new system for grading recommendations in evidence based guidelines. BMJ. 2001;323:334-336.
  • Harper MB. Update on the management of the febrile infant. Clinical Pediatric Emergency Medicine. 2004;5:5-12.
  • Health on the Net. HON Code of Conduct (HONcode) for Medical and Health Web sites. Available at: http://www.hon.ch/HONcode/Conduct.html. Accessed October 18, 2004.
  • Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002;360:7-22.
  • Hensel WA, Dickey NW. Teaching professionalism: passing the torch. Acad Med. 1998;73:865-870.
  • Hippocrates. Aphorisms. Adams F, trans. Available at http://classics.mit.edu/Hippocrates/aphorisms.1.i.html Accessed October 28, 2004.
  • Hoyt DB. Clinical practice guidelines. Am J Surg. 1997;173:32-34.
  • Hsieh TC, Kuperman GJ, Jaggi T, et al. Characteristics and consequences of drug-allergy alert overrides in a computerized physician order entry system. J Am Med Inform Assoc. 2004;11:482-491.
  • Hyams AL, Brandenburg JA, Lipsitz SR, Shapiro DW, Brennan TA. Practice guidelines and malpractice litigation: a two-way street. Ann Intern Med. 1995;122:450-455.
  • Hyams AL, Shapiro DW, Brennan TA. Medical practice guidelines in malpractice litigation: an early retrospective. J Health Polit Policy Law. 1996;21:289-313.
  • Immergluck LC, Cull WL, Schwartz A, Elstein AS. Cost-effectiveness of universal compared with voluntary screening for human immunodeficiency virus among pregnant women in Chicago. Pediatrics. 2000;105:E54.
  • Institute of Medicine. Committee to Advise the Public Health Service on Clinical Practice Guidelines. In: Field MJ, Lohr KN, eds. Clinical Practice Guidelines: Directions for a New Program. Washington, DC: National Academy Press; 1990. Available at: http://www.nap.edu/books/ 0309043468/html/. Accessed October 18, 2004.
  • Irwin KL, Valdiserri RO, Holmberg SD. The acceptability of voluntary HIV antibody testing in the United States: a decade of lessons learned. AIDS. 1996;10:1707-1717.
  • Jong P, Demers C, McKelvie RS, et al. Angiotensin receptor blockers in heart failure: a meta-analysis of randomized controlled trials. J Am Coll Cardiol. 2002;39:463-470.
  • Joo E, Carmack A, Garcia-Buñuel E, et al. Implementation of guidelines for HIV counseling and voluntary testing of pregnant woman. Am J Public Health. 2000;90:273-276.
  • Kassirer JP, Cecil JS. Inconsistency in evidentiary standards for medical testimony, disorder in the courts. JAMA. 2002;288:1382-1387.
  • Kelly JT, Swartwout JE. Development of practice parameters by physician organizations. QRB Qual Rev Bull. 1990;16:54-57.
  • Kinney ED. National coverage policy in the Medicare program: problems & proposals for change. St. Louis University Law Journal. 1988;32:869-970.
  • Krasinski K, Borkowsky W, Bebenroth D, et al. Failure of voluntary testing for human immunodeficiency virus to identify infected parturient women in a high-risk population. N Engl J Med. 1988; 318:185.
  • Laffel G, Blumenthal D. The case for using industrial quality management science in health care organizations. JAMA. 1989;262:2869-2873.
  • Leapfrog Group. Leapfrog Fact Sheet. Available at: http://www.leapfroggroup.org/about_us/leapfrog-factsheet. Accessed October 18, 2004.
  • Legato MJ. Report of the Task Force on Research on Women's Health for the 21st Century: a personal overview. J Gend Specif Med. 1998;1:54-60.
  • Maiese M. Procedural justice. Available at: http://www.beyondintractability.org/m/procedural_justice.jsp. Accessed September 17, 2004.
  • Mastroianni AC, Faden R, Federman D, eds. Women and Health Research: Ethical and Legal Issues of Including Women in Clinical Studies. Washington, DC: National Academy Press; 1994. Available at http://www.nap.edu/books/030904992X/html/. Accessed November 8, 2004.
  • McAlister FA, Taylor L, Teo KK, et al, for the Clinical Quality Improvement Network (CQIN) Investigators. The treatment and prevention of coronary heart disease in Canada: do older patients receive efficacious therapies? J Am Geriatr Soc. 1999;47:811–818.
  • Merenstein D. Winners and losers. JAMA. 2004;291:15-16.
  • Miller RA, Gardner RM. Summary recommendations for responsible monitoring and regulation of clinical software systems. Ann Intern Med. 1997;127:842-845.
  • Moher D, Schulz KF, Altman D, for the CONSORT Group. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA. 2001;285:1987-1991.
  • Nakchbandi IA, Longenecker JC, Ricksecker MA, Latta RA, Healton C, Smith DG. A decision analysis of mandatory compared with voluntary HIV testing in pregnant women. Ann Intern Med. 1998; 128:760-767.
  • National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143-3421.
  • National Cholesterol Education Program. Second report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). Circulation. 1994;89:1333-1445.
  • National Institutes of Health. NIH guidelines on the inclusion of women and minorities as subjects in clinical research. NIH Guide for Grants and Contracts. 1994; 23(11). Available at http://grants.nih.gov/grants/guide/notice-files/not94-100.html. Accessed November 2, 2004.
  • National Institutes of Health. NIH Strategic Research Plan and Budget to Reduce and Ultimately Eliminate Health Disparities FY 2002-2006. Vol. 1; Bethesda, MD: National Institutes of Health; 2002. Available at: http://ncmhd.nih.gov/our_programs/strategic/pubs/VolumeI_031003EDrev.pdf. Accessed November 2, 2004.
  • Office of Research on Women's Health. Agenda For Research On Women's Health for the 21st Century: A Report of the Task Force on the NIH Women's Health Research Agenda for the 21st Century. Bethesda, MD: National Institutes of Health; 1999. Available at: http://www4.od.nih.gov/orwh/agenda_book_1.pdf. Accessed November 2, 2004.
  • Office of Research on Women's Health. Outreach Notebook for the Inclusion, Recruitment, and Retention of Women and Minority Subjects in Clinical Research: Principal Investigators' Notebook. Bethesda, MD: National Institutes of Health; 2002. Available at: http://www4.od.nih.gov/orwh/outreach.pdf. Accessed November 2, 2004.
  • Office of Research on Women's Health. Science Meets Reality: Recruitment and Retention of Women in Clinical Studies, and the Critical Role of Relevance. Bethesda, MD: National Institutes of Health; 2003. Available at: http://www4.od.nih.gov/orwh/SMR_Final.pdf. Accessed November 2, 2004.
  • Office of Research on Women's Health. Recruitment and Retention of Women in Clinical Studies: A Report of the Workshop sponsored by the Office of Research on Women's Health. Bethesda, MD: National Institutes of Health;1995. NIH Pub. No. 95-3756.
  • Oldenettel D, Dye TD, Artal R. Prenatal HIV screening in pregnant women: a medical legal review. Birth. 1997;24:165-172.
  • Owen WF, Szczech LA, Frankenfield DL. Healthcare system interventions for inequality in quality: corrective action through evidence-based medicine. J Natl Med Assoc. 2002;94(8 suppl):83S–91S.
  • Pantell RH, Naber M, Lamar R, et al. Fever in the first six months of life: risks of underlying serious infection. Clin Pediatr. 1980;19:77-82.
  • Pantell RH, Newman TB, Bernzweig J, et al. Management and outcomes of care of fever in early infancy. JAMA. 2004;291:1203-1212.
  • Parra EO, Doran TI, Ivy LM, Aranda JM, Hernandez C. Concerns of pregnant women about being tested for HIV: a study in a predominately Mexican-American population. AIDS Patient Care STDS. 2001;15:83-93.
  • Peloso PM, Carroll LJ, Cassidy JD, et al. Critical evaluation of the existing guidelines on mild traumatic brain injury. J Rehabil Med. 2004;43 Suppl:106-112.
  • Pinn VW, Chunko MT, Cooper Z. Setting the research agenda for the 21st century. J Womens Health. 1997;6:517-520.
  • Pinn VW, Roth C, Bates AC, et al., and the NIH Tracking/Inclusion Committee. Monitoring Adherence to the NIH Policy on the Inclusion of Women and Minorities as Subjects in Clinical Research Comprehensive Report: Tracking of Human Subjects Research Reported in FY 2002 and FY 2003. Bethesda, MD: National Institutes of Health; 2004. Available at: http://www4.od.nih.gov/orwh/Updated_2002-2003.pdf. Accessed November 2, 2004.
  • Pinn VW. Challenges in advancing women's health in the 21st century: Perspectives from the Office of Research on Women's Health. Ethn Dis 2001; 11:177-180.
  • Pinn VW. From policy to science: enhancing the inclusion of diverse ethnic groups in aging research. In: Curry L and Jackson J, eds. The Science of Inclusion: Recruiting and Retaining Racial and Ethnic Elders in Health Research. Washington, DC: The Gerontological Society of America; 2003.
  • Pinn VW. Sex and gender factors in medical studies: implications for health and clinical practice. JAMA. 2003;289:397-400.
  • Pinn VW. Women's health research: progress and future directions. Acad Med. 1999;74:1104-1105.
  • Provisional Committee on Pediatric AIDS. Perinatal human immunodeficiency virus testing. Pediatrics. 1995;95:303-307.
  • Quill TE, Brody H. Physician recommendations and patient autonomy: finding a balance between physician power and patient choice. Ann Intern Med. 1996;125:763-769.
  • Ransom SB, Studdert DM, Dombrowski MP, Mello MM, Brennan TA. Reduced medicolegal risk by compliance with obstetric clinical pathways: a case-control study. Obstet Gynecol. 2003;101:751-755.
  • Rawlins MD, Culyer AJ. National Institute for Clinical Excellence and its value judgments. BMJ. 2004;329:224-227.
  • Resnik DB. Setting biomedical research priorities in the 21st century. Virtual Mentor. 2003;5. Available at: http://www.ama-assn.org/ama/pub/category/10571.html. Accessed September 28, 2004.
  • Roberts KB. Young, febrile infants: A 30-year odyssey ends where it starts. JAMA. 2004; 291:1261-1262.
  • Rogers WA, Braunack-Mayer A. Practical Ethics for General Practice. Oxford: Oxford University Press; 2004:79-100.
  • Rogers WA. Evidence-based medicine and justice: a framework for looking at the impact of EBM on vulnerable or disadvantaged groups. J Med Ethics. 2004;30:141-145.
  • Rombauer IS, Becker MR, Becker E. Joy of Cooking. New York: Scribner; 1997.
  • Rothenberg KH, Paskey SJ. The risk of domestic violence and women with HIV infection: implications for partner notification, public policy, and the law. Am J Public Health. 1995;85:1569-1576.
  • Rubin RJ, Mendelson DN. How much does defensive medicine cost? J Am Health Policy. 1994;4:7-15.
  • Saarni SI, Gylling HA. Evidence based medicine guidelines: a solution to rationing or politics disguised as science? J Med Ethics. 2004;30:171-175.
  • Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS. Evidence based medicine: what it is and what it isn't. BMJ. 1996;312:71-72.
  • Sackett DL, Straus SE, Richardson WS, et al. Evidence-Based Medicine: How to Practice and Teach EBM. 2nd ed. Edinburgh: Churchill Livingstone; 2000:1.
  • Sacks FM, Pfeffer MA, Moye LA, et al, for the Cholesterol and Recurring Events trial investigators. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med. 1996;335:1001-1009.
  • Scandinavian Simvastatin Survival Study (4S). Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344:1383-1389.
  • Schuller v Merrell Dow Pharmaceuticals, Inc., 727 F.Supp.570 (SD Cal.1989).
  • Schunemann HJ, Best D, Vist G, et al, for the GRADE Working Group. Letters, numbers, symbols and words: how to communicate grades of evidence and recommendations. CMAJ. 2003;169:677-680.
  • Sculpher M, Drummond M, O'Brien B. Effectiveness, efficiency, and NICE. BMJ. 2001;322:943–944.
  • Sever PS, Dahlof B, Poulter NR, et al, for the ASCOT Investigators. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet. 2003;361:1149-1158.
  • Shaneyfelt TM, Mayo-Smith MF, Rothwangl J. Are guidelines following guidelines? The methodological quality of clinical practice guidelines in the peer-reviewed medical literature. JAMA. 1999;281:1900-1905.
  • Shepherd J, Blauw GJ, Murphy MB, et al. PROSPER study group. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. PROspective Study of Pravastatin in the Elderly at Risk. Lancet. 2002;360:1623-1630.
  • Simpson WM, Johnstone FD, Boyd FM, Goldberg DJ, Hart GJ, Prescott RJ. Uptake and acceptability of antenatal HIV testing: randomised controlled trial of different methods of offering the test. BMJ. 1998;316:262-267.
  • Stead EA Jr. The limitations of teaching. Pharos. 1969;32:54-57.
  • Steinbrook R. Nursing in the crossfire. N Engl J Med. 2002;346:1757-1766.
  • Steinman MA, Sands LP, Covinsky KE. Self-restriction of medications due to cost in seniors without prescription coverage. J Gen Intern Med. 2001;16:793-799.
  • Stoto MA, Almario DA, McCormick MC, eds. for the U.S. Institute of Medicine, Committee on Perinatal Transmission of HIV, Board on Children Youth and Families. Reducing the Odds: Preventing Perinatal Transmission of HIV in the United States. Washington, DC: National Academy Press; 1999. Available at: http://www.nap.edu/books/0309062861/html/index.html. Accessed October 20, 2004.
  • Tamblyn R, Huang A, Perreault R, et al. The medical office of the 21st century (MOXXI): effectiveness of computerized decision-making support in reducing inappropriate prescribing in primary care. CMAJ. 2003;169:549-556.
  • Tennenbaum D. Blue Cross and Blue Shield Association's perspective on the common diagnostic testing guidelines. J Gen Intern Med. 1989;4:553-554.
  • The Long-term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Eng J Med. 1998;339:1349-1357.
  • The T.J. Hooper, 60 F 2nd 737 (2d Cir 1932).
  • Tonelli MR. Integrating evidence into clinical practice: an alternative to evidence-based approaches. J Eval Clin Pract. (In press).
  • Tonelli MR. The philosophical limits of evidence-based medicine. Acad Med. 1998;73:1234-1240.
  • Tsai TL, Fridsma DB, Gatti G. Computer decision support as a source of interpretation error: the case of electrocardiograms. J Am Med Inform Assoc. 2003;10:478-483.
  • Turnock BJ, Kelly CJ. Mandatory premarital testing for human immunodeficiency virus. The Illinois experience. JAMA. 1989;261:3415-3418.
  • Ubel PA, Hirth RA, Chernew ME, Fendrick AM. What is the price of life and why doesn't it increase at the rate of inflation? Arch Intern Med. 2003;163:1637-1641.
  • US Public Health Service. Revised US Public Health Service Recommendations for Human Immunodeficiency Virus Screening of Pregnant Women. Washington, DC; 2000.
  • Washington DL, Bernstein SJ, Kahan JP, et al. Reliability of clinical guideline development using mail-only versus in-person expert panels. Med Care. 2003;41:1374-1381.
  • White LJ, Ball JR. Clinical Efficacy Assessment Project of the American College of Physicians. Int J Technol Assess Health Care. 1985;1:69-74.
  • Wilcox S, Shumaker SA, Bowen DJ, et al. Promoting adherence and retention to clinical trials in special populations: a women's health initiative workshop. Control Clin Trials. 2001;22:279-289.
  • Williams JW Jr, Aguilar C, Cornell J, et al. Antibiotics for acute maxillary sinusitis. Cochrane Database Syst Rev. 2003(2);CD000243.
  • Woolf SH. Manual for Clinical Practice Guideline Development. Rockville, Maryland: Agency for Health Care Policy and Research; 1991.
  • Young, IM. Justice and the Politics of Difference. Princeton, NJ: Princeton University Press; 1990.
The viewpoints expressed on this site are those of the authors and do not necessarily reflect the views and policies of the AMA.